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Background: The uterine leiomyosarcoma represents the most frequent malignant gynecologic 
mesenchymal tumor that often develops distant metastases. The diagnosis of these tumors is nowadays 
still a challenge and the direct implication of the small non-coding RNAs (MicroRNAs ) in gene 
expression, tumor initiation and tumor progression has already been revealed in scientific studies. 
Because the aberrant microRNA (miRNA) expression patterns show a diagnostic value as tumor 
markers, we aimed to identify the gene expression level of miRNA-1 (miR-1) and the protein targets in 
uterine leiomyosarcoma.
Methods: Using the specific cell line - SK-UT-1 with similar biological characteristics of the 
uterine leiomyosarcoma tissue, in comparison to ovarian carcinoma cell lines: OVCAR-3, TOV-21 and 
SK-OV-3, and cell lines of mouse heart-muscle (HL-1), we were able to perform real time PCRs and 
RNA-Isolation arrays, transient and stabile transfection programs with lipofectamine reagents. Tissue 
samples of uterine leiomyosarcoma and healthy uterus were again analyzed by means of transfection 
and isolation arrays. The electrophoresis using protein targets of the miR-1 (p38 and ERK 1/2 widely 
expressed protein kinase intracellular signaling molecules and involved in functions including the 
regulation of meiosis, mitosis, und postmitotic functions) was also integrated.
Results: The analysis of the SK-UT-1 cell line have shown significant differences in comparison 
to the other studied cell lines, respectively a reduced expression of the miR-1 molecules. The same 
results were observed in the process of transfection and electrophoresis of the human tissues, where the 
lowest expression of the miR-1 was evidenced in the uterine leiomyosarcomas. The specific protein 
targets of miR-1 have shown positive Western Blot signals.
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Conclusions: The miR-1 non coding molecules may improve our understanding of disease 
development, progression and gene expression of the uterine leiomyosarcoma. Further prospective 
translational studies in order to evaluate miR-1 as a prognostic factor are needed. 
Key words: MIR-1, leiomyosarcoma, Western Blot.
257. MATURITY ONSET DIABETES OF THE YOUNG: CURRENT TRENDS 
AND CONCEPTS
Covantev Serghei
Scientific adviser: Perciuleac Ludmila, PhD, Associate Professor, Department of Molecular Biology and 
Human Genetics, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic 
of Moldova
Introduction: Diabetes is a worldwide problem with polygenic etiology and high rate of 
mortality and morbidity. By 2030 the number of individuals with diabetes worldwide may rise to 472 
million. Eighty per cent of them will be in low and middle income countries. In some of these countries 
diabetic drugs and insulin are inaccessible or rather expensive which eventually affect the whole 
healthcare system. Nevertheless 10% of patients with type 1 and 5% of patients with type 2 diabetes 
have a monogenic form of this disease. 
Materials and methods: We studies a case series of patients with maturity onset diabetes of the 
young (MODY) with the review of the literature of the last 10 years using PubMed and Scopus.
Discussion results: Nationwide studies show that the prevalence of MODY ranges from about 
1% to 35% of all diabetes mellitus cases. Current data describes 11 types of MODY. The most frequent 
are MODY 1, 2 and 3. To date, several transcriptional factors and an enzyme are Associated with 
MODY. There are several characteristic traits that may help to diagnose the disease without molecular 
-cell antibodies, less than 30 years 
of age, no insulin resistance, family history of diabetes, detectable C-peptide more than 0,2 nmol/l 
outside the honeymoon period, GST more than 0.2 nmol/l.
Conclusion: In Republic of Moldova there are approximately 80 thousand diabetic patients, 
which mean that they represent somewhere 50% of the endocrine diseases. Some of these patients may 
have MODY diabetes which requires different treatment options and has a better clinical prognosis then 
type 1 and 2 diabetes mellitus.
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